Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
PG-102 and placebo were identical in appearance and administered in the same manner to maintain blinding
Similarly, the LEADER trial with liraglutide showed a numerically higher, though non-significant, rate of diabetic retinopathy events compared to placebo (HR, 1.15
Parallel reporter assays identify altered regulatory role of rs684232 in leading to prostate cancer predisposition
These assessments ensure that beneficial metabolic effects persist and no adverse metabolic changes emerge
Downstream effectors of mTOR including hypoxia-induced factor-1 (HIF-1), hexokinase (HK), pyruvate kinase M2 (PKM2), and enolase2 will then directly stimulate aerobic glycolysis and inhibit oxidative phosphorylation in cancer cells, thus leading to the metabolic reprogramming in PDA tissue (Iqbal et al., 2013
US$ 27.11
US$ 21.61
US$ 27.73
US$ 28.89
US$ 21.43
US$ 24.42
US$ 20.03
US$ 29.49
